Pharmafile Logo
Pharmafocus logo
Advanced Search
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018
Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …

News
theresa_may_-_credit_arno_mikkor

May announces £75m prostate cancer boost

April 10, 2018
Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …

News
msd

Keytruda scores big as a first-line monotherapy in NSCLC patients with any level of PD-L1 expression

April 10, 2018
Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

Closely following the news that Keytruda (pembrolizumab) had failed in the treatment of unresectable or metastatic melanoma as a combination …

News
woman-1246587_960_720

Media reports over Parkinson’s drug risk hit Acadia hard

April 10, 2018
Manufacturing and Production, Medical Communications Acadia Pharmaceutical, biotech, drugs, pharma, pharmaceutical

Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …

News
brain-1787622_640

Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia

April 10, 2018
Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma

A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …

News
iannone

Immunomedics’ whirlwind in the C-suite continues

April 10, 2018
Manufacturing and Production, Medical Communications AstraZeneca, Immunomedics, Seattle Genetics, biotech, drugs, pharma, pharmaceutical

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …

News
fighting_cancer

Looking to the future of oncology

April 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …

Feature
800px-prostate_cancer_1

Almost 40% of UK prostate cancer cases are diagnosed late, according to report

April 9, 2018
Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer

A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …

News
instagram-3198093_960_720

Facebook takes action against drug peddlers on Instagram

April 9, 2018
Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …

News
roche_glass_building

Tecentriq third time lucky after NICE nod in lung cancer

April 9, 2018
Sales and Marketing NICE, Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq

After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small …

News
merckincweb

Keytruda combo fails at Phase 3 in metastatic melanoma

April 9, 2018
Research and Development, Sales and Marketing Incyte, MSD, keytruda, pharma, trial failure

Shares in biopharma firm Incyte were sent reeling by as much as 20% when the company announced that the results …

News

Novartis CEO makes mark with $8.7bn AveXis acquisition

April 9, 2018
Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical

Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …

News
humira_abbott__4

Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar

April 6, 2018
Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …

News
roche_close

Roche suffers Ocrevus knockback by NICE

April 6, 2018
Medical Communications, Sales and Marketing Ocrevus, Roche, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

Roche’s multiple sclerosis drug, Ocrevus (ocrelizumab), has been a big new growth driver for the company, especially in the US, …

News
shutterstock_274590824

J&J pays out $37m in damages over claims its talc contains asbestos

April 6, 2018
Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …

News
china_block_001_takeda

Takeda move for Shire looks increasingly likely

April 6, 2018
Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical

Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …

News
luigi_costa_credit_nordic_nanovector_headshot

Nordic Nanovector CEO steps down as company delays R&D timelines

April 5, 2018
Medical Communications, Research and Development, Sales and Marketing Luigi Costa, Nordic Nanovector, pharma

Norwegian biopharmaceutical firm Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from …

News
cystic_fibrosis_insider_interview

Transforming cystic fibrosis treatment

April 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …

Feature
roche

Roche snaps up Inception neuroscience program

April 5, 2018
Sales and Marketing Pipeline Therapeutics, Roche, biotech, drugs, pharma, pharmaceutical

Back in 2014, Roche entered into strategic collaboration with Inception Sciences to look into the regenerative medicines space for multiple …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026